SYNLOGIC, INC. Finance Lease, Liability, to be Paid, Year Three
SYNLOGIC, INC. (SYBX) had Finance Lease, Liability, to be Paid, Year Three of $2.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree · last filed 2019-11-12
- 2019-09-30: Finance Lease, Liability, to be Paid, Year Three $2.00K.
- 2019-06-30: Finance Lease, Liability, to be Paid, Year Three $2.00K.
- 2019-03-31: Finance Lease, Liability, to be Paid, Year Three $2.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Three |
|---|---|
| 2019-09-30 | $2.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |